These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34058036)

  • 1. An open-label non-inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma.
    Ray A; Manikanta J; Singh K; Gabra P; Vyas S; Singh G; Xess I; Sethi P; Meena VP; Soneja M; Sinha S; Wig N; Kabra SK
    Mycoses; 2021 Sep; 64(9):1038-1044. PubMed ID: 34058036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of nebulised amphotericin B deoxycholate (Fungizone
    Otu AA; Langridge P; Denning DW
    Mycoses; 2019 Nov; 62(11):1049-1055. PubMed ID: 31479538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
    Purcell IF; Corris PA
    Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.
    Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Min WS; Shin WS
    Korean J Intern Med; 2006 Sep; 21(3):165-72. PubMed ID: 17017665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Boogaerts M; Winston DJ; Bow EJ; Garber G; Reboli AC; Schwarer AP; Novitzky N; Boehme A; Chwetzoff E; De Beule K;
    Ann Intern Med; 2001 Sep; 135(6):412-22. PubMed ID: 11560454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.
    Yoshida I; Saito AM; Tanaka S; Choi I; Hidaka M; Miyata Y; Inoue Y; Yamasaki S; Kagoo T; Iida H; Niimi H; Komeno T; Yoshida C; Tajima F; Yamamoto H; Takase K; Ueno H; Shimomura T; Sakai T; Nakashima Y; Yoshida C; Kubonishi S; Sunami K; Yoshida S; Sakurai A; Kaneko Y; Miyazaki Y; Nagai H
    Mycoses; 2020 Aug; 63(8):794-801. PubMed ID: 32391919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
    Agarwal R; Vishwanath G; Aggarwal AN; Garg M; Gupta D; Chakrabarti A
    Mycoses; 2013 Sep; 56(5):559-70. PubMed ID: 23496375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of pulmonary aspergilloma. Clinical review].
    Martínez J; Márquez M; Sola O; Arés J; Grarau J
    Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):413-5. PubMed ID: 11153205
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of Intravenous Itraconazole Versus Liposomal Amphotericin B as Empirical Antifungal Therapy in Hematological Malignancy with Persistent Fever and Neutropenia: Study Protocol for a Multicenter, Prospective, Randomized Non-inferiority Trial.
    Saito AM; Yoshida I; Tanaka S; Sawamura M; Hidaka M; Yoshida S; Uike N; Kaneko Y; Miyazaki Y; Nagai H
    Kurume Med J; 2021 Dec; 66(4):239-246. PubMed ID: 34544939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
    Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma.
    Kravitz JN; Berry MW; Schabel SI; Judson MA
    Chest; 2013 May; 143(5):1414-1421. PubMed ID: 23117277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.
    Sehgal IS; Dhooria S; Muthu V; Prasad KT; Aggarwal AN; Chakrabarti A; Choudhary H; Garg M; Agarwal R
    Lancet Infect Dis; 2022 Jul; 22(7):1052-1061. PubMed ID: 35429465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
    Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).
    Chishimba L; Langridge P; Powell G; Niven RM; Denning DW
    J Asthma; 2015 Apr; 52(3):289-95. PubMed ID: 25158109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
    Caillot D
    Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pulmonary aspergilloma in cystic fibrosis by percutaneous instillation of amphotericin B via indwelling catheter.
    Ryan PJ; Stableforth DE; Reynolds J; Muhdi KM
    Thorax; 1995 Jul; 50(7):809-10. PubMed ID: 7570423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of 61 patients with pulmonary aspergilloma.
    Kawamura S; Maesaki S; Tomono K; Tashiro T; Kohno S
    Intern Med; 2000 Mar; 39(3):209-12. PubMed ID: 10772121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
    Godet C; Couturaud F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Bourdin A; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Bergeron A; Gondouin A; Frat JP; Flament T; Camara B; Priou P; Brun AL; Laurent F; Ragot S; Cadranel J; ; Godet C; Couturaud F; Cadranel J; Frat JP; Brun AL; Laurent F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Gondouin A; Flament T; Camara B; Priou P; Ragot S
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34764182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
    Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
    Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
    Fujita M; Tao Y; Kajiki A; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
    J Infect Chemother; 2012 Oct; 18(5):668-74. PubMed ID: 22350405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.